FOXO3 and cancer: To our knowledge, our study is the first to have comprehensively assessed the association of DNA methylation at FOXO3 measured in blood with major health outcomes: cancer risk (3624 cases), cancer survival (2286 deaths), and mortality in an older participant sample of the MCCS (354 deaths).